Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K AMENDMENT NO. 1 - EPIRUS Biopharmaceuticals, Inc. | d717154d10ka.htm |
| EX-31.2 - EX-31.2 - EPIRUS Biopharmaceuticals, Inc. | d717154dex312.htm |
| EX-31.1 - EX-31.1 - EPIRUS Biopharmaceuticals, Inc. | d717154dex311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of Zalicus Inc. (the “Company”), do hereby certify that to their knowledge:
1) the Company’s Form 10-K/A for the fiscal year ended December 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2) the information contained in the Company’s Form 10-K/A for the fiscal year ended December 31, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /S/ MARK H.N. CORRIGAN |
| Mark H.N. Corrigan |
| President and Chief Executive Officer (principal executive officer) |
| /S/ JUSTIN A. RENZ |
| Justin A. Renz |
| Executive Vice President, Chief Financial Officer and Treasurer (principal financial and accounting officer) |
Dated: April 30, 2014